o Study Start-up Phase – Clinical study document generation, CRO/partner selection process, feasibility and site selection, study plan generation.
o Conduct Phase – Risk management assessment, Site quality score card evaluation, quality trend matrix assessment, and CRO/partner oversight, audit/inspection readiness for site and organization level.
· Perform on-site quality oversight visit to ensure sites and vendors to have study inspection ready.
· Supervise and/or Conduct internal system review to identify gaps and suggest corrective and preventive actions
· Perform trend analysis provide strategic support to senior management and project team to ensure department upgradation.
· Facilitate end-to-end Regulatory inspections and/or internal audits.
· Support the management in implementation of Corrective/Preventative Action process for audits (CAPA)
· Perform vendor assessment and qualification visit buid partnership for CT activities.
· Coordinate with department heads to assess and implement training requirements.
· Supervise development and revision of organizational level process documents including – Standard Operating Procedures, WIs etc.
· Provide training on Clinical Trial Quality-related topics, guidelines, SOPs and regulatory changes
· Line management support in mentoring and performance review for the reporting team members.
Regulatory Role:
· Lead on local and global clinical trial registry (CTRI, ClinicaTrial.gov etc) management.
· New drug application and subsequent regulatory submission using SUGAM platform for all phases of CT
Additional Responsibility:
· Operations lead and project management responsibilities for in-house PK-PD Insulin clamp study; including attending NDAC meeting at DCGI office.
· Operations lead and project management responsibilities for ADME (early phase) NEC molecule.
Accomplishments:
Accomplishments:
Clinical Operations, Project Management, Global Clinical Trials, Clinical Monitoring